CONCLUSION
Biguanides, especially metformin, have a cardiovascular pharmacological, immunomodulatory, antiviral and antioxidant effect, thus, they are a potential therapeutic tool supporting the treatment of COVID-19. Thus, experimental studies are necessary to confirm its effects in relation to SARS-CoV-2 and the clinical evolution of the disease.